Poor image, branding problems harm US FDA's ability to attract top scientists
This article was originally published in Clinica
Executive Summary
With the potential the US FDA’s budget could be slashed by 8.2%, or about $318 million, if the across-the-board sequestration funding cuts kick in come January – something President Barack Obama insists will not happen – and its public image again in shambles after failing to take action to prevent the current meningitis calamity caused by compounded drugs, the agency’s prospects for winning top talent probably are not the best right now.